QUBT:NASDAQQuantum Computing Inc. Analysis
Data as of 2026-07-18 - not real-time
$7.80
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Quantum Computing Inc. (QUBT) trades at $7.80, just above its 20‑day support of $7.41 and well below the 200‑day SMA of $10.96, indicating a price cushion but a bearish technical backdrop. The MACD line sits at –0.61 versus a signal at –0.47, generating a bearish histogram, while the 14‑day RSI is around 38, suggesting modest downside momentum but not yet oversold. Volatility is extreme at 92% over the past 30 days and beta exceeds 3.4, meaning the stock moves sharply with market swings. Fundamentally, the company posts a massive revenue surge of 94% YoY yet still operates with negative gross and operating margins, a -74% max drawdown, and negative cash flows, though it holds ~ $986 M in cash against modest debt. The recent acquisition of NHanced Semiconductors and a $2 B U.S. government grant to the sector provide a catalyst narrative, while analysts (6) collectively rate the stock as a “buy” with a median price target of $18, implying over 130% upside. However, the lack of earnings, a forward PE of –20.5, and a price‑to‑sales ratio above 400 underscore the speculative nature of the valuation.
In summary, QUBT offers a high‑risk, high‑reward profile: strong cash reserves and sector tailwinds offset by severe profitability challenges and volatile price action.
In summary, QUBT offers a high‑risk, high‑reward profile: strong cash reserves and sector tailwinds offset by severe profitability challenges and volatile price action.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and RSI indicating limited near‑term upside
- Price near technical support with decreasing volume
- Recent acquisition may need integration time
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus “buy” and median target price of $18
- Sector grant and growing commercial interest in quantum hardware
- Large cash runway to fund R&D and product rollout
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Potential breakthrough revenue from EQC and photonic products
- Strategic positioning in a nascent, high‑growth quantum computing market
- Undervalued price‑to‑book ratio relative to long‑term asset base
Key Metrics & Analysis
Financial Health
Revenue Growth9364.10%
P/E Ratio-20.5
ROE-4.37%
ROA-4.25%
Debt/Equity0.34
P/B Ratio1.1
Op. Cash Flow$-35286000
Free Cash Flow$-40361376
Industry P/E32.8
Technical Analysis
TrendBearish
RSI38.0
Support$7.41
Resistance$11.30
MA 20$9.11
MA 50$10.08
MA 200$10.96
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Target Price$18.33
Upside/Downside135.04%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta3.48
Volatility92.08%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.